Tissue expression
Cell line expression
Protein structure

DGCR2

DiGeorge syndrome critical region gene 2
DGS-C, IDD, KIAA0163, LAN, SEZ-12 
Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
161 antibodies from 25 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Proteintech Group
1 antibody
antibodies-online
57 antibodies
Novus Biologicals
5 antibodies
Biorbyt
8 antibodies
Invitrogen Antibodies
8 antibodies
Atlas Antibodies
2 antibodies
GeneTex
1 antibody
Cusabio Biotech Co., Ltd
1 antibody
NovoPro Bioscience Inc.
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
Aviva Systems Biology
3 antibodies
OriGene
3 antibodies
Abnova Corporation
2 antibodies
Acris Antibodies GmbH
1 antibody
St John's Laboratory
1 antibody
ProSci
2 antibodies
R&D Systems
1 antibody
MyBioSource
3 antibodies
Creative Diagnostics
2 antibodies
Creative Biolabs
5 antibodies
MilliporeSigma / Merck KGaA
3 antibodies
United States Biological
13 antibodies
Abbexa
2 antibodies